As of April 30, 2025, Petros Pharmaceuticals (PTPI) has a market cap of $695,748 Dollars USD. According to our data, Petros Pharmaceuticals is ranked No.9254 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 30, 2025 | $695,748 Dollars |
-84.40%
|
Dec 31, 2024 | $4.46 M |
-72.06%
|
Dec 29, 2023 | $15.96 M |
-39.48%
|
Dec 30, 2022 | $26.37 M |
-93.00%
|
Dec 31, 2021 | $0.38 B |
-24.32%
|
Dec 31, 2020 | $0.50 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Pfizer
PFE
|
$130.73 B |
-0.001 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$794.90 B |
-0.026 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$342.32 B |
-0.001 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$77.05 B |
0.003 M
|
![]() UK
|
![]() Merck
MRK
|
$212.01 B |
-0.001 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$375.13 B |
0.006 M
|
![]() USA
|
![]() Amgen
AMGN
|
$152.20 B |
0.126 B
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$98.62 B |
0.002 M
|
![]() USA
|
![]() Sanofi
SNY
|
$128.86 B |
0.003 M
|
![]() France
|
![]() Teva Pharmaceutical Industries
TEVA
|
$18.23 B |
0.362 B
|
![]() Israel
|
![]() Viatris
VTRS
|
$9.96 B |
0.000 M
|
![]() USA
|
![]() Novartis
NVS
|
$224.23 B |
0.160 B
|
![]() Switzerland
|
![]() AstraZeneca
AZN
|
$222.30 B |
0.004 M
|
![]() UK
|
Market Cap | = | PTPI Stock Price | * | PTPI Shares Outstanding |
= | $0.01 | * | 53.52 M | |
= | $695,748 Dollars |